MS Views and News

MS Views and News
Click Logo - MS Views & News is Dedicated to Providing You with Multiple Sclerosis News and Information

Monday, February 9, 2009

February 5, 2009 - (the 6th edition of 2009)

In this week's edition:
  1. THIS Week's Postings ( 21 MS related + 4 others )
  2. We have a listing of Informational sources found on our website.
  3. A how to, on how to know what is being posted to the blog, as it is being posted.
  4. Information on the Bio Ness L300 for Foot drop.
  5. A New Reader Comment (others are welcomed at any time)
  6. Have you heard of OHG - the BuZZ
  7. Or of the New FaceBook site called "FIGHT MS"
  8. Or of MS Blog Central - This is mainly for those who blog each day
  9. On our website, take a look at the Shared MS Resources
  10. Want to know of Pseudobulbar Affect?
  11. Misc. MS News on Teva's Copaxone and Biogen's Tysabri and recurring info on Vitamin "D"

WHERE YOU SEE the (feed) symbol: - on the MS Blog address bar ( also known as a URL), click it to subscribe for immediate knowledge of posts (postings), being made to Stu's Views & M.S. Related News.Why wait sometimes up to a full week, before you see what I am posting...
Now, I am asking for your help. - I am asking that you reach out to others whom you know affected by MS ( patients or caregivers ). Then provide them with our website address (
Ask them to register, so that they too can receive what you receive each week. Tell them what they are missing or how you feel about what you receive from here. - Thank you
Recently, I have been receiving many questions about the Bio Ness L300 and Hyperbaric Oxygen.
If you need more information on either of these subjects, please open our homepage to see the
Information ads found for both of these products.
In addition to the above two, we have many other sources of information available to you on our website.
If you have not really taken the time to look at our site, please take 30 minutes to do so...
Other topics found on our homepage are:
  • Cooling Vests
  • Social Security Disability
  • MS Lifelines (Rebif / Novantrone / Rx Financial Support and more)
  • a Pseudobulbar Research Study
  • a Laquinimod Research Study
  • Neurological Associates Research (oral Fumarate, oral Fingolimod and Campath)
  • Tysabri
  • The MS Centers of Florida Foundation
  • MS Center of Miami
  • Housing and Assistive Technologies (Housing Modifications for the disabled)
  • The Myelin Project
  • MS Refugees
  • The Multiple Sclerosis Foundation (MSF)
  • MS Friends
  • MS Society of Canada
  • MSRC - UK - Multiple Sclerosis Resource Centre
View The MS Views Website to learn more of the Pseudobulbar Affect
To READ or View any of these topics, >> CLICK to Visit our Website <<
Have heard of this recently created website: OHG - the BuZZ - Click to see what they have for you
A friend with MS named Susan, invites you to join the Facebook group "Fight MS"
To see more details and confirm this group invitation, click: this link
A recent reader comment (Helps me to toot my horn):

Hey Stuart,

My name is Rita and I subscribe to your newsletter. I just wanted to take a moment and thank you for all you do… J Your newsletter is always informative, and covers such a variety of things – and your website is amazing! I have yet to be able to investigate it all… I need more time in the day, lol. I also wanted to commend you on the way you do your fundraising. You are never pushy, never make people feel guilty, never make people feel they need to give an arm and a leg. The kind of person you are shines thru….

I am 45 and was just diagnosed a year ago. I was on Rebif for several months, and now I am on Tysabri, as my symptoms did not respond to the Rebif and things were progressing – plus it made me wicked sick all the time. I have had a lot to wrap my head around in a very short time, and have spent the past year reading and researching and educating myself. I am in the medical field myself, and have a pretty good working knowledge of things…. But I still had so much to learn, and I keep learning. Knowledge somehow helps give me comfort I guess.. J

Your site has been one I go back to again and again.. I always find something interesting or informative there. Thank you again for all you do, and the time you spend doing it. I just wanted you to know how much your hard work is appreciated…

J Hope you have a great day!


This weeks' (25) Postings: ( YES , I was Busy this week) (Click the link you want to read)
On our website, take a look at the Share Links that we now have found on the right side of each page.
(including one now from the UK)
If you know of other organizations that want to do this with MS Views and News, please ask them to contact me.
MISC. MS News:
Teva's Copaxone gets EU approval in MS prevention
Forbes - NY,USA
AP , 02.04.09, 01:26 PM EST European regulators approved Teva Pharmaceutical Industries Ltd.'s multiple sclerosis drug Copaxone as a preventative treatment, ...
Earnings Preview: Biogen Idec
Forbes - NY,USA
OVERVIEW: A slowdown in new patients taking the multiple sclerosis drug Tysabri hung over the company throughout the quarter. In all, the company and its ...
Vitamin D is ray of sunshine for multiple sclerosis patients
Times Online - UK
Multiple sclerosis could be prevented through daily vitamin D supplements, scientists told The Times last night. The first causal link has been established ...
MS Blog Central - Created and updated by Lisa Emrich of the Carnival of Bloggers - a very complete MS Blogs Listing for those with time
To see our blog roll, be sure to visit the Stu's Views and MS Views Blog to scan the Blogs listed on our site.

e-Newsletter Disclaimer:

***Editor's Note: The intent of this newsletter is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


No comments:

Post a Comment

Leave comments only that directly pertain to each article.
All solicitations will be removed.